From diagnostic algorithms and clinical decision support tools to AI-driven monitoring platforms, Software as a Medical Device (SaMD) is reshaping healthcare—and regulators are paying very close attention.
Software doesn’t just support medical devices anymore.
In many cases, the software is the medical device.
This blog exists to make sense of that regulatory landscape.
Why “Software as a Medical Device” Is Different (and Harder Than It Looks)
Traditional medical devices fail in visible ways. Software fails silently.
A bug in a SaMD product can:
- Misclassify a diagnosis
- Delay treatment
- Introduce bias
- Produce incorrect clinical outputs without obvious alarms
Because of that, regulators don’t just care about what the software does—they care deeply about how it’s developed, validated, maintained, and changed over time.
That’s where frameworks like:
- FDA SaMD guidance
- EU MDR
- ISO 13485
- IEC 62304
- Software validation and lifecycle controls
come into play.
And yes—this is where many teams get overwhelmed.
The Regulatory Puzzle: FDA, EU MDR, and Global Expectations
SaMD rarely lives in just one market.
A single product may need to comply with:
- FDA expectations for software validation, cybersecurity, and clinical performance
- EU MDR requirements for lifecycle documentation, post-market surveillance, and risk management
- Quality Management Systems (QMS) aligned with ISO 13485
- Software lifecycle controls defined in IEC 62304
These aren’t isolated checklists. They overlap, reinforce each other, and—when misunderstood—create gaps that regulators will absolutely find.
This blog will focus on connecting those dots.
Quality Management Systems: The Backbone of Software as a Medical Device Compliance
If software is the brain of a SaMD product, the QMS is the nervous system.
A compliant SaMD organization needs more than great developers. It needs:
- Design controls that actually reflect how software evolves
- Risk management that includes software hazards and unintended use
- Change control that doesn’t break compliance every sprint
- Validation that proves the software is fit for its intended medical purpose
ISO 13485 isn’t just paperwork—it’s the structure that makes SaMD development defensible during audits and inspections.
IEC 62304: Not a Waterfall Prison (Despite the Myths)
One of the biggest misconceptions in SaMD is that IEC 62304 forces waterfall development.
It doesn’t.
IEC 62304 is about:
- Controlled software lifecycle processes
- Risk-based classification of software items
- Traceability from requirements to code to testing
- Managing change without losing control
Agile, DevOps, and continuous delivery can work—when mapped correctly to regulatory expectations. We’ll break that mapping down step by step in future posts.
What This Blog Will Cover
You can expect deep dives on topics like:
- FDA vs EU MDR expectations for SaMD
- Practical ISO 13485 implementation for software teams
- IEC 62304 explained in plain language
- Software validation without killing development velocity
- Risk management for algorithms, AI, and updates
- Common audit findings—and how to avoid them
- Documentation strategies that scale with product growth
Who This Blog Is For
If you’re:
- A software engineer entering medical devices
- A QA/RA professional dealing with SaMD for the first time
- A startup founder trying to build compliant software without slowing innovation
- A medtech professional tired of vague regulatory advice
You’re in the right place.
Final Thought
SaMD regulation isn’t about slowing innovation.
It’s about earning trust—clinically, technically, and regulatorily.
This blog is here to help you do exactly that.
Welcome to the Software as aMedical Device journey.